Carl Zeiss secures sale of Acri.Tec

Article

Carl Zeiss Meditec has now completed its acquisition of Acri.Tec AG.

Carl Zeiss Meditec has now completed its acquisition of Acri.Tec AG.

Acri.Tec, which generated sales revenues of €15.4 million in the 2006 financial year, specializes in innovative implants for ophthalmic surgery. The two companies' products complement each other well and the acquisition will expand Carl Zeiss Meditec's rapidly-growing ophthalmic surgery division.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.